ZA934199B - Carrier system against gnrh - Google Patents

Carrier system against gnrh

Info

Publication number
ZA934199B
ZA934199B ZA934199A ZA934199A ZA934199B ZA 934199 B ZA934199 B ZA 934199B ZA 934199 A ZA934199 A ZA 934199A ZA 934199 A ZA934199 A ZA 934199A ZA 934199 B ZA934199 B ZA 934199B
Authority
ZA
South Africa
Prior art keywords
carrier system
gnrh
system against
against gnrh
elicits
Prior art date
Application number
ZA934199A
Other languages
English (en)
Inventor
Anna Van Der Zee
Irma Marianne Van Die
Willem Pieter Martin Hoekstra
Josephus Theodorus Gielen
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA934199B publication Critical patent/ZA934199B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Gyroscopes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
ZA934199A 1992-06-18 1993-06-14 Carrier system against gnrh ZA934199B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92201775 1992-06-18

Publications (1)

Publication Number Publication Date
ZA934199B true ZA934199B (en) 1994-01-10

Family

ID=8210697

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA934199A ZA934199B (en) 1992-06-18 1993-06-14 Carrier system against gnrh

Country Status (18)

Country Link
US (2) US5684145A (fr)
EP (1) EP0578293B1 (fr)
JP (1) JPH0656696A (fr)
KR (1) KR100293025B1 (fr)
AT (1) ATE188737T1 (fr)
AU (1) AU667715B2 (fr)
BR (1) BR9302408A (fr)
CA (1) CA2098533C (fr)
DE (1) DE69327553T2 (fr)
DK (1) DK0578293T3 (fr)
ES (1) ES2142848T3 (fr)
GR (1) GR3033086T3 (fr)
HU (1) HU217096B (fr)
MX (1) MX303646A (fr)
NZ (1) NZ247907A (fr)
PT (1) PT578293E (fr)
TW (1) TW240232B (fr)
ZA (1) ZA934199B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826116D0 (en) * 1988-11-08 1988-12-14 Danbiosyst Ltd Adhesive drug delivery composition
EP0596959B1 (fr) * 1991-07-26 2000-03-29 Commonwealth Scientific And Industrial Research Organisation Systeme d'administration de vaccin peptidique produisant son propre adjuvant et production du vaccin
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
AU1532795A (en) * 1994-01-27 1995-08-15 Gx Biosystems A/S Receptor specific bacterial adhesins and their use
US6635740B1 (en) * 1997-03-27 2003-10-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Ligand/lytic peptide compositions and methods of use
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
US6013770A (en) * 1997-07-21 2000-01-11 Washington State University Chimeric contraceptive vaccines
US6258782B1 (en) * 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
US6656906B1 (en) * 1998-05-20 2003-12-02 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
AUPP807399A0 (en) 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
DE60017211T2 (de) * 1999-02-17 2005-06-02 Pfizer Products Inc., Groton Fusionsproteine mit Trägern welche eine doppelte Immunantwort induzieren
WO2001085208A2 (fr) * 2000-05-05 2001-11-15 Cytos Biotechnology Ag Jeu ordonne d'antigenes moleculaires
US6783761B2 (en) 2000-05-05 2004-08-31 Aphton Corporation Chimeric peptide immunogens
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
AU2002362696B2 (en) * 2001-10-05 2008-05-29 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
WO2004016282A1 (fr) 2002-07-19 2004-02-26 Cytos Biotechnology Ag Matrices d'antigenes amyloides $g(b)1-6
US7537767B2 (en) 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
WO2004084940A1 (fr) 2003-03-26 2004-10-07 Cytos Biotechnology Ag Encapsulation d'oligonucleotides immunostimulateurs dans des particules pseudovirales, procedes de preparation et utilisations
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
DE3783425T2 (de) * 1986-10-13 1993-05-13 Solvay Mikroorganismen, die fremdproteinenthaltende pili tragen, isolierte pili, verfahren zur ausscheidung von proteinen in verwendung dieser pili und deren nutzen.
AU616662B2 (en) * 1987-04-27 1991-11-07 Commonwealth Scientific And Industrial Research Organisation Peptide production by protein engineering
DE3871489D1 (de) * 1987-10-26 1992-07-02 Akzo Nv Impfstoff gegen e.coli-blutvergiftung bei gefluegel.
US5036047A (en) * 1988-09-29 1991-07-30 Pitman-Moore, Inc. Method and composition for preventing conception
GB8826116D0 (en) * 1988-11-08 1988-12-14 Danbiosyst Ltd Adhesive drug delivery composition
GB2228262B (en) * 1989-01-25 1992-10-07 Nat Inst Immunology Antigenic derivative of gnrh
NL8900726A (nl) * 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.

Also Published As

Publication number Publication date
ATE188737T1 (de) 2000-01-15
JPH0656696A (ja) 1994-03-01
KR100293025B1 (ko) 2001-09-17
HUT68554A (en) 1995-06-28
DE69327553D1 (de) 2000-02-17
CA2098533A1 (fr) 1993-12-19
NZ247907A (en) 1994-12-22
BR9302408A (pt) 1994-01-11
DE69327553T2 (de) 2000-08-10
AU667715B2 (en) 1996-04-04
ES2142848T3 (es) 2000-05-01
HU9301764D0 (en) 1993-10-28
MX303646A (es) 1994-05-31
EP0578293A1 (fr) 1994-01-12
GR3033086T3 (en) 2000-08-31
PT578293E (pt) 2000-06-30
KR940000115A (ko) 1994-01-03
AU4134393A (en) 1993-12-23
US6019983A (en) 2000-02-01
HU217096B (hu) 1999-11-29
EP0578293B1 (fr) 2000-01-12
DK0578293T3 (da) 2000-06-26
TW240232B (fr) 1995-02-11
CA2098533C (fr) 2005-08-16
US5684145A (en) 1997-11-04

Similar Documents

Publication Publication Date Title
ZA934199B (en) Carrier system against gnrh
CA2123612A1 (fr) Proteine hybride entre la proteine cs de plasmodium et l'antigene de surface du virus de l'hepatite b
TW273514B (fr)
GB2210557B (en) Vaccine containing tumor antigens and refined detoxified endotoxin as an adjuvant.
AU4399085A (en) Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
IL102687A (en) Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
GR3029791T3 (en) Improved immunogenic compositions against human gastrin 17
GR3035198T3 (en) Medical preparation containing the subunit p40 of interleukin 12.
NZ333226A (en) Immunstimulating lipid formulation
AU5941486A (en) Tetanus vaccine from cloned antigen
GB9001728D0 (en) Antigenic derivative of gnrh
AU643959B2 (en) Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration
ES8801126A1 (es) Un procedimiento para preparar una vacuna para proteger seres humanos contra infeccion por plasmodium falciparum
AU2521792A (en) Chicken anaemia agent vaccine
HU9600757D0 (en) Adjuvant based on colloidal iron compounds
MX9300883A (es) Polipeptidos de vacuna.
GR3019859T3 (en) Synthetic vaccine for the specific induction of cytotoxic T-lymphocytes
DK665688D0 (da) Polypeptid
IL101639A0 (en) Recombinant influenza vaccines
USRE37517E1 (en) Portion of an optical scanner
ZA893737B (en) Modulation of the immune response system
ITFI920071A0 (it) Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vogeesndk
ZA882095B (en) Synthetic peptide antigens for the detection of hiv-1 infection
GB9214435D0 (en) Vaccine carrier or adjuvant
ZA892301B (en) Synthetic peptide antigens for the detection of htlv-1 infection